Abstract
Background: The early part of the central aortic pressure pulse, with amplitude (PI – Pd), is generated by left ventricular ejection, while the latter part (or augmented pressure), with amplitude (Ps – Pi), is generated by the reflected wave arriving during systole. The effects of arterial vasodilator agents, especially nitrates, on central aortic systolic blood pressure are grossly underestimated by sphygmomanometric measurements of brachial artery pressure.
Hypothesis: The objective of this study was to investigate the potential for use of central arterial pulse wave analysis, obtained noninvasively from the radial pulse, in determining the interaction between sildenafil and the nitric oxide donor drug glyceryl trinitrate (GTN).
Methods: Central aortic pressure waveforms were generated from noninvasively measured radial artery pressure waveforms and subjected to pulse wave analysis to determine the interactionbetween sildenafil and transdermally applied GTN.
Results: Transdermal GTN (2.5, 5.0, and 15 mg per 24‐h patches) alone caused no consistent change in sphygmomanometer‐determined systolic or diastolic pressures, but there was a consistent, dose‐related fall in amplitude of the augmented systolic pressure, (Ps – Pi), of 4.0,7.0, and 11 mmHg, respectively, with little change in diastolic pressure. The 2.5 mg patch caused a fall of 4.0 mmHg in aortic systolic pressure, while augmentation index (AIx) fell from 20 to 11% and pulse pressure fell 18%. When oral sildenafil (50 mg) was administered after GTN (2.5 mg), aortic systolic pressure fell another 4.0 mmHg. This decrease in systolic pressure caused a fall in AIx to almost 0.0%; pulse pressure fell another 9.0%.
Conclusion: These modifications in aortic systolic and pulse pressure are due primarily to reduction in wave‐reflection amplitude and are not detected by sphygmomanometer‐measured brachial artery pressure.
Keywords: wave reflection, augmented pressure, pulse pressure, augmentation index, pulse wave velocity
Full Text
The Full Text of this article is available as a PDF (98.7 KB).
References
- 1. Conti CR, Pepine CJ, Sweeney M: Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol 1999; 83 (5A): 29C–34C [DOI] [PubMed] [Google Scholar]
- 2. Jackson G, Benjamin N, Jackson N, Allen MJ: Effects of sildenafil citrate on human hemodynamics. Am J Cardiol 1999; 83 (5A): 13C–20C [DOI] [PubMed] [Google Scholar]
- 3. Zusman RM, Morales A, Glasser DB, Osterloh IH: Overall cardiovascular profile of sildenafil citrate. Am J Cardiol 1999; 83 (5A): 35C–44C [DOI] [PubMed] [Google Scholar]
- 4. Kloner RA, Brown M, Prisant LM, Collins M: Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group. Am J Hypertens 2001; 14 (1): 70–73 [DOI] [PubMed] [Google Scholar]
- 5. Cheitlin MD, Hutter AM Jr, Brindis RG, Ganz P, Kaul S, Russell RO Jr, Zusman RM: ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol 1999; 33 (1): 273–282 [DOI] [PubMed] [Google Scholar]
- 6. Webb DJ, Muirhead GJ, Wulff M, Sutton JA, Levi R, Dinsmore WW: Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol 2000; 36 (1): 25–31 [DOI] [PubMed] [Google Scholar]
- 7. Kloner RA, Zusman RM: Cardiovascular effects of sildenafil citrate and recommendations for its use. Am J Cardiol 1999; 84 (5B): 11N–17N [DOI] [PubMed] [Google Scholar]
- 8. Murrell W: Nitroglycerin as a remedy for angina pectoris. Lancet 1879; 1: 80–81, 151–152, 225–227 [Google Scholar]
- 9. O'Rourke M, Safar M, Dzau V: Arterial Vasodilation, Mechanisms and Therapy, p. 220–223. Philadelphia: Lea and Febiger, 1993. [Google Scholar]
- 10. Yaginuma T, Avolio AP, O'Rourke MF, Nichols WW, Morgan JJ, Roy P, Baron D, Branson J, Feneley M: Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res 1986; 20 (2)153–160 [DOI] [PubMed] [Google Scholar]
- 11. Kelly RP, Gibbs HH, O'Rourke MF, Daley JE, Mang K, Morgan JJ, Avolio AP: Nitroglycerine has more favourable effects on left ventricular afterload apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990; 11: 138–144 [DOI] [PubMed] [Google Scholar]
- 12. Nichols W, O'Rourke M: McDonald's Blood Flow in Arteries, p. 450–476. London: Arnold, 1998. [Google Scholar]
- 13. Wilkinson IB, Fuchs SA, Jansen LM, Spratt JC, Murray GD, Cock‐croft JR, Webb DJ: Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998; 16: 2079–2084 [DOI] [PubMed] [Google Scholar]
- 14. Siebenhofer A, Kemp C, Sutton A, Williams B: The reproducability of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmomanometry. J Hum Hypertens 1999; 13: 625–629 [DOI] [PubMed] [Google Scholar]
- 15. Nichols WW, Edwards DG: Arterial elastance and wave reflection augmentation of systolic blood pressure: Deleterious effects and implications for therapy. J Cardiovasc Pharmacol Therapeut 2001; 6: 5–21 [DOI] [PubMed] [Google Scholar]
- 16. Simkus GJ, Fitchett DH: Radial arterial pressure measurements may be a poor guide to the beneficial effects of nitroprusside on left ventricular systolic pressure in congestive heart failure. Am J Cardiol 1990; 66: 323–326 [DOI] [PubMed] [Google Scholar]
- 17. Takazawa K, Tanaka N, Takeda K, Kuroso F, Ibukiyama C: Underestimation of vasodilator effects of nitroglycerine by upper limb blood pressure. Hypertension 1995; 26: 520–523 [DOI] [PubMed] [Google Scholar]